BardelliAlberto University of Torino, Dept of Oncology and IFOM ETItaly

BardelliAlberto
Alberto Bardelli is Professor at the Dept. of Oncology at the University of Torino School of Medicine and Director of the Laboratory of Molecular Oncology at the Candiolo Cancer Institute in Italy. Graduated cum laude at the University of Torino, he holds a Ph.D. in Biochemistry and Molecular biology from the University College London (UCL) followed by a post-doctoral fellowship in the laboratory directed by Bert Vogelstein at the Howard Hughes Medical Institute at the Johns Hopkins University in Baltimore. Prof Bardelli and his laboratory at the Candiolo Cancer Institute have pioneered the combined use of genomics, patients’ avatars and liquid biopsies to accurately predict tumor's response and resistance to targeted agents. Discoveries from his group led to the development of innovative diagnostic tests, and therapeutic regimens currently in clinical use for colorectal cancer patients. Prof Bardelli has been President of the European Association for Cancer Research (EACR) and received several awards, including the ESMO Translational Research Award in 2017 and the Guido Venosta Award, given by AIRC (Italian Association for Cancer Research) and Presidency of Italian Republic, in 2020.

Monday, 16 June 2025

Time Session
10:20
12:00
BardelliAlberto Co-Chair Italy
JerónimoCarmen Co-Chair Portugal
  • γδ T Cells in Cancer and Cancer Immunotherapy
    SantosBruno Silva Speaker Portugal
  • Zebrafish Cancer Avatars for Clinical Decision-making
    FiorRita Speaker Portugal
  • IL-7 and IL-7R: Subverting Lymphoid Development Towards Leukemia
    BarataJoão T. Speaker Portugal
  • Association Between CDH1 Germline Variants and Cancer Phenotypes
    OliveiraCarla Speaker Portugal
  • Questions & Answers
Auditorium 6+7

Thursday, 19 June 2025

Time Session
10:00
11:15
BardelliAlberto Moderator Italy
DiveCaroline Moderator United Kingdom
Auditorium 1

Tuesday, 17 June 2025

Time Session
09:20
10:55
CohenMerav Co-Chair Israel
SamuelsYardena Co-Chair Israel
  • Engineered dendritic cell therapy
    De PalmaMichele Speaker Switzerland
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • Exploiting immune surveillance to target colorectal cancer
    BardelliAlberto Speaker Italy
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • Translation Dysregulation In Cancer as a Source for Targetable Antigens
    SamuelsYardena Speaker Israel
Auditorium 1
17:30
18:15
BardelliAlberto Chair Italy
  • Cancer Metabolism
    WhiteEileen Keynote Speaker United States
Auditorium 1

Wednesday, 18 June 2025

Time Session
15:20
16:55
BardelliAlberto Co-Chair Italy
DiazLuis Alberto Co-Chair United States
  • DNA repair-dependent immunogenic liabilities in colorectal cancer: the opportunity comes from the errors
    GermanoGiovanni Speaker Italy
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • Immunoprevention in Lynch Syndrome
    DiazLuis Alberto Speaker United States
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • Title to be announced
    PaganiMassimiliano Speaker Italy
Auditorium 6+7
17:30
18:15
BardelliAlberto Chair Italy
BernardsRene Co-Chair Netherlands
Auditorium 1